Cell therapy for cornea swelling after cataract surgery
Treatments studied
Part of Eyes & vision clinical trials.
This trial tests a simple cell treatment for a swollen cornea caused by cataract surgery. It aims to help your cornea become clear again without a full transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your cornea (the clear front part of your eye) is swollen but not severely scarred.
- The swelling happened after cataract surgery or lens removal (not from injury, infection, or a genetic problem).
- You are between 21 and 80 years old.
- You are not pregnant.
- You do not have an allergy to antibiotics or antifungal medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 trial tests a new, lab-made tissue transplant to improve corneal clarity in people with certain types of corneal endothelium failure (eye swelling) caused by specific conditions. The main goal is to check safety and see if vision and corneal health improve.
This trial tests an investigational cell therapy called EO2002 for people with corneal edema (swelling of the clear front part of the eye) caused by endothelial dysfunction, which can happen with Fuchs dystrophy or after cataract surgery. The treatment aims to restore the inner layer of the cornea to reduce swelling and improve vision.
This trial tests a new treatment that implants donated corneal cells attached to a tiny gel onto the back of the cornea. It aims to reduce swelling and improve vision in people with corneal conditions like Fuchs dystrophy or swelling after cataract surgery.
This trial tests if using special cells from your own urine can help repair the inner layer of your cornea (the clear front part of your eye). It may be an option if you have damage to these cells and have already had at least one cornea transplant.
This trial tests a new corneal implant to treat corneal swelling caused by Fuchs' dystrophy or after cataract surgery. It aims to improve vision and reduce the need for a full corneal transplant.
This trial studies a treatment for people with Fuchs’ dystrophy that affects the clear layer at the back of the cornea. It may help improve how clear your vision is after the cornea can no longer pump fluid out properly.
Hear when a new Bullous Keratopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.